CD274 and non-small cell lung carcinoma: As an example, very low levels of anti-PD(L)1 activity have been reported in patients with Non-Small Cell Lung Cancer (NSCLC) harboring the majority of driver alterations that are often associated with low mutational burden and a non-smoking history.